Mamamia on MSN1h
The surprising Ozempic side effect that's worse for women.
As the popularity of weight loss drugs like Ozempic continues to climb, a disturbing pattern is emerging — and it's impacting ...
Futurism on MSN13h
Hims Is Begging Customers to Lobby the FDA to Keep Its Ozempic Knockoffs Legal
Hims — the next gen telehealth startup that made waves by taking the eye contact out of erectile dysfunction treatment. Of ...
News-Medical.Net on MSN12h
Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...
News-Medical.Net on MSN59m
New trial shows oral semaglutide reduces cardiovascular events in diabetes patients
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...
Will Using Semaglutide Increase Your Risk of Thyroid Cancer?
New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...
The American Journal of Managed Care12h
Semaglutide Demonstrates Enhanced Walking Capacity in ACC.25 STRIDE Data
STRIDE investigator Marc Bonaca, MD, MPH, University of Colorado School of Medicine, highlights how the data could provide insight into peripheral artery disease and type 2 diabetes treatment options.
Ozempic can help people with diabetes walk better despite poor blood flow to legs: Why Lancet study is significant
Semaglutide, the diabetes and weight loss drug that’s commonly known as Ozempic, can help patients of peripheral artery ...